-
2
-
-
0037432755
-
The human genome project: Lessons from large-scale biology
-
Collins FS, Morgan M, Patrinos A. The human genome project: lessons from large-scale biology. Science 2003; 300:286-290.
-
(2003)
Science
, vol.300
, pp. 286-290
-
-
Collins, F.S.1
Morgan, M.2
Patrinos, A.3
-
4
-
-
0035819474
-
Implications of the human genome project for medical science
-
Collins FS, McKusick VA. Implications of the human genome project for medical science. JAMA 2001; 285:540-544.
-
(2001)
JAMA
, vol.285
, pp. 540-544
-
-
Collins, F.S.1
McKusick, V.A.2
-
5
-
-
0032429154
-
A DNA polymorphism discovery resource for research on human genetic variation
-
Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 1998; 8:1229-1231.
-
(1998)
Genome Res
, vol.8
, pp. 1229-1231
-
-
Collins, F.S.1
Brooks, L.D.2
Chakravarti, A.3
-
6
-
-
0036649742
-
Association of genes to genetically inherited diseases using data mining
-
Perez-Iratxeta C, Bork P, Andrade MA. Association of genes to genetically inherited diseases using data mining. Nat Genet 2002; 31:316-319.
-
(2002)
Nat Genet
, vol.31
, pp. 316-319
-
-
Perez-Iratxeta, C.1
Bork, P.2
Andrade, M.A.3
-
7
-
-
0035861452
-
Correction of sickle cell disease in transgenic mouse models by gene therapy
-
Pawliuk R, Westerman KA, Fabry ME, et al. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 2001; 294:2368-2371.
-
(2001)
Science
, vol.294
, pp. 2368-2371
-
-
Pawliuk, R.1
Westerman, K.A.2
Fabry, M.E.3
-
8
-
-
0033557267
-
Status of gene therapy for cystic fibrosis lung disease
-
Boucher RC. Status of gene therapy for cystic fibrosis lung disease. J Clin Invest 1999; 103:441-445.
-
(1999)
J Clin Invest
, vol.103
, pp. 441-445
-
-
Boucher, R.C.1
-
9
-
-
0034834535
-
Gene therapy in cystic fibrosis
-
Flotte TR, Laube BL. Gene therapy in cystic fibrosis. Chest 2001; 120(suppl 3):124S-131S.
-
(2001)
Chest
, vol.120
, Issue.SUPPL. 3
-
-
Flotte, T.R.1
Laube, B.L.2
-
10
-
-
0038713400
-
Genetic research: Mining for medical treasures
-
Delude C. Genetic research: mining for medical treasures (editorial). FASEB J 2003; 17:787.
-
(2003)
FASEB J
, vol.17
, pp. 787
-
-
Delude, C.1
-
11
-
-
0346690146
-
"Iceland Inc."? On the ethics of commercial population genomics
-
Merz JF, McGee GE, Sankar P. "Iceland Inc."? On the ethics of commercial population genomics. Soc Sci Med 2004; 58:1201-1209.
-
(2004)
Soc Sci Med
, vol.58
, pp. 1201-1209
-
-
Merz, J.F.1
McGee, G.E.2
Sankar, P.3
-
12
-
-
0141994853
-
Towards integrated clinico-genomic models for personalized medicine: Combining gene expression signatures and clinical factors in breast cancer outcomes prediction
-
Nevins JR, Huang ES, Dressman H, Pittman J, Huang AT, West M. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet 2003; 12(spec no 2):R153-R157.
-
(2003)
Hum Mol Genet
, vol.12
, Issue.SPEC. NO. 2
-
-
Nevins, J.R.1
Huang, E.S.2
Dressman, H.3
Pittman, J.4
Huang, A.T.5
West, M.6
-
13
-
-
0036009619
-
The thiopurine S-methyltransferase gene locus: Implications for clinical pharmacogenomics
-
McLeod HL, Siva C. The thiopurine S-methyltransferase gene locus: implications for clinical pharmacogenomics. Pharmacogenomics 2002; 3:89-98.
-
(2002)
Pharmacogenomics
, vol.3
, pp. 89-98
-
-
McLeod, H.L.1
Siva, C.2
-
15
-
-
0013526775
-
Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis
-
Okutsu J, Tsunoda T, Kaneta Y, et al. Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis. Mol Cancer Ther 2002; 1:1035-1042.
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 1035-1042
-
-
Okutsu, J.1
Tsunoda, T.2
Kaneta, Y.3
-
16
-
-
0037125369
-
Genotype-phenotype relationship in Brugada syndrome: Electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients
-
Smits JP, Eckardt L, Probst V, et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002; 40:350-356.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 350-356
-
-
Smits, J.P.1
Eckardt, L.2
Probst, V.3
-
17
-
-
0346157999
-
Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest
-
Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003; 108:3092-3096.
-
(2003)
Circulation
, vol.108
, pp. 3092-3096
-
-
Brugada, J.1
Brugada, R.2
Brugada, P.3
-
18
-
-
2442701017
-
An update on implantable cardioverter-defibrillator guidelines
-
Epstein AE. An update on implantable cardioverter-defibrillator guidelines. Curr Opin Cardiol 2004; 19:23-25.
-
(2004)
Curr Opin Cardiol
, vol.19
, pp. 23-25
-
-
Epstein, A.E.1
-
19
-
-
0035775486
-
Pharmacogenomics: The inherited basis for interindividual differences in drug response
-
Evans WE, Johnson JA. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet 2001; 2:9-39.
-
(2001)
Annu Rev Genomics Hum Genet
, vol.2
, pp. 9-39
-
-
Evans, W.E.1
Johnson, J.A.2
-
20
-
-
0347526061
-
Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics
-
Hoehe MR, Timmermann B, Lehrach H. Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics. Curr Pharm Biotechnol 2003; 4:351-378.
-
(2003)
Curr Pharm Biotechnol
, vol.4
, pp. 351-378
-
-
Hoehe, M.R.1
Timmermann, B.2
Lehrach, H.3
-
21
-
-
0036399958
-
Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: The way forward
-
Terra SG, Johnson JA. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward. Am J Cardiovasc Drugs 2002; 2:287-296.
-
(2002)
Am J Cardiovasc Drugs
, vol.2
, pp. 287-296
-
-
Terra, S.G.1
Johnson, J.A.2
-
22
-
-
10744220794
-
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
-
Helgadottir A, Manolescu A, Thorleifsson G, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004; 36:233-239.
-
(2004)
Nat Genet
, vol.36
, pp. 233-239
-
-
Helgadottir, A.1
Manolescu, A.2
Thorleifsson, G.3
-
23
-
-
0033368153
-
Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer
-
Albanell J, Baselga J. Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer. Drugs Today (Barc) 1999; 35:931-946.
-
(1999)
Drugs Today (Barc)
, vol.35
, pp. 931-946
-
-
Albanell, J.1
Baselga, J.2
-
24
-
-
0032805316
-
Clindamycin, metronidazole, and chloramphenicol
-
Kasten MJ. Clindamycin, metronidazole, and chloramphenicol. Mayo Clin Proc 1999; 74:825-833.
-
(1999)
Mayo Clin Proc
, vol.74
, pp. 825-833
-
-
Kasten, M.J.1
-
25
-
-
0035869767
-
[(11)C, (127)I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites
-
Fischman AJ, Bonan AA, Babich JW, et al. [(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites. Synapse 2001; 39:332-342.
-
(2001)
Synapse
, vol.39
, pp. 332-342
-
-
Fischman, A.J.1
Bonan, A.A.2
Babich, J.W.3
-
26
-
-
1842556156
-
PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus
-
Kostakoglu L, Goldsmith SJ. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 2004; 45:56-68.
-
(2004)
J Nucl Med
, vol.45
, pp. 56-68
-
-
Kostakoglu, L.1
Goldsmith, S.J.2
-
27
-
-
0037612510
-
Biomarkers in imaging: Realizing radiology's future
-
Smith JJ, Sorensen AG, Thrall JH. Biomarkers in imaging: realizing radiology's future. Radiology 2003; 227:633-638.
-
(2003)
Radiology
, vol.227
, pp. 633-638
-
-
Smith, J.J.1
Sorensen, A.G.2
Thrall, J.H.3
-
28
-
-
0034083918
-
Quantitative measurements of medical images for pharmaceutical clinical trials: Comparison between on-site and off-site assessments
-
Sahani D, Saini S, Fatuga GA, et al. Quantitative measurements of medical images for pharmaceutical clinical trials: comparison between on-site and off-site assessments. AJR Am J Roentgenol 2000; 174:1159-1162.
-
(2000)
AJR Am J Roentgenol
, vol.174
, pp. 1159-1162
-
-
Sahani, D.1
Saini, S.2
Fatuga, G.A.3
-
29
-
-
2442647209
-
Engineering of technetium-99-binding artificial receptors for imaging gene expression
-
Simonova M, Shtanko O, Sergeyev N, Weissleder R, Bogdanov A Jr. Engineering of technetium-99-binding artificial receptors for imaging gene expression. J Gene Med 2003; 5:1056-1066.
-
(2003)
J Gene Med
, vol.5
, pp. 1056-1066
-
-
Simonova, M.1
Shtanko, O.2
Sergeyev, N.3
Weissleder, R.4
Bogdanov Jr., A.5
-
30
-
-
0036859888
-
MRI of transgene expression: Correlation to therapeutic gene expression
-
Ichikawa T, Hogemann D, Saeki Y, et al. MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia 2002; 4:523-530.
-
(2002)
Neoplasia
, vol.4
, pp. 523-530
-
-
Ichikawa, T.1
Hogemann, D.2
Saeki, Y.3
-
31
-
-
0242332217
-
Genetic discrimination: Time to act
-
Collins FS, Watson JD. Genetic discrimination: time to act. Science 2003; 302:745-746.
-
(2003)
Science
, vol.302
, pp. 745-746
-
-
Collins, F.S.1
Watson, J.D.2
|